Paul Wotton

Track

Insider profile

Currently holds positions in Cynata Therapeutics Ltd and Vericel Corp

Performance

Overall performance
2.6
Performance over holding periods
2.6
30 days 90 days 120 days
Average return -10% 8.2% 15.1%
Success rate 18% 68% 82%
Transactions
9 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chairman of the Board Cynata Therapeutics Ltd Feb. 28, 2017 -
Independent Director Vericel Corp Jan. 1, 2017 -
Director Vericel Corp Jan. 7, 2015 - Jan. 1, 2017
President, Chief Executive Officer, Director Ocata Therapeutics Inc July 31, 2014 - Feb. 10, 2016
President, Chief Executive Officer Ocata Therapeutics Inc July 21, 2014 - July 31, 2014
President, Chief Executive Officer, Director Antares Pharma Inc Oct. 10, 2008 - June 23, 2014
Paul Wotton's trades of Vericel Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-13 2026-05-11
US Vericel Corp (VCEL)
S Sale
37,747 +48.4%
114.58
US$3,284,026 		37,747 +48.4% 114.58 US$3,284,026
2026-05-13 2026-05-11
US Vericel Corp (VCEL)
S Sale
39,950 -49.6%
180.86
US$686,898 		39,950 -49.6% 180.86 US$686,898
2026-05-11 2026-05-11
US Vericel Corp (VCEL)
PrS Proposed sale
460
372.84
US$3,884,004 		460 372.84 US$3,884,004
2025-12-04 2025-12-03
US Vericel Corp (VCEL)
S Sale
2,500 -8.9%
37.83
US$94,575 		2,500 -8.9% 37.83 US$94,575
2025-12-03 2025-12-03
US Vericel Corp (VCEL)
PrS Proposed sale
2,500
37.83
US$94,575 		2,500 37.83 US$94,575
2025-12-04 2025-12-02
US Vericel Corp (VCEL)
S Sale
2,500 -8.2%
37.97
US$94,925 		2,500 -8.2% 37.97 US$94,925
2025-12-02 2025-12-02
US Vericel Corp (VCEL)
PrS Proposed sale
2,500
37.97
US$94,919 		2,500 37.97 US$94,919
2024-12-05 2024-12-04
US Vericel Corp (VCEL)
S Sale
2,600 -8.7%
58.72
US$152,672 		2,600 -8.7% 58.72 US$152,672
2024-12-04 2024-12-04
US Vericel Corp (VCEL)
PrS Proposed sale
2,600
83.76
US$217,782 		2,600 83.76 US$217,782
2023-12-15 2023-12-14
US Vericel Corp (VCEL)
S Sale
5,000 -15.7%
37.31
US$186,550 		5,000 -15.7% 37.31 US$186,550
2023-12-14 2023-12-14
US Vericel Corp (VCEL)
PrS Proposed sale
5,000
37.10
US$185,485 		5,000 37.10 US$185,485
2021-05-17 2021-05-14
US Vericel Corp (VCEL)
S Sale
5,000 -15.8%
50.52
US$252,611 		5,000 -15.8% 50.52 US$252,611
2021-05-13 2021-05-12
US Vericel Corp (VCEL)
S Sale
2,200 -6.5%
48.88
US$107,534 		2,200 -6.5% 48.88 US$107,534
2021-05-13 2021-05-11
US Vericel Corp (VCEL)
S Sale
13,448 -28.5%
50.11
US$673,922 		13,448 -28.5% 50.11 US$673,922
2019-01-04 2019-01-02
US Vericel Corp (VCEL)
PlS Planned sale
17,500 -100.0%
16.83
US$294,539 		17,500 -100.0% 16.83 US$294,539
2019-01-04 2019-01-02
US Vericel Corp (VCEL)
PlS Planned sale
5,000 -100.0%
16.83
US$84,154 		5,000 -100.0% 16.83 US$84,154